首页 工具
登录
购物车
KRCA-0008

KRCA-0008

产品编号 T2641   CAS 1472795-20-2
别名: KRCA 0008, KRCA0008

KRCA-0008 是高效的、选择性的 ALK/Ack1 抑制剂,对ALK 和Ack1的IC50值分别为12nM 和4nM,显示出非hERG 依赖性药物活性。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
KRCA-0008 Chemical Structure
KRCA-0008, CAS 1472795-20-2
规格 价格/CNY 货期 数量
1 mg ¥ 206 现货
5 mg ¥ 538 现货
10 mg ¥ 913 现货
25 mg ¥ 1,630 现货
50 mg ¥ 3,220 现货
100 mg ¥ 4,770 现货
500 mg ¥ 9,870 现货
1 mL * 10 mM (in DMSO) ¥ 555 现货
产品目录号及名称: KRCA-0008 (T2641)
点击图片重新获取验证码
选择批次  
纯度: 96.19%
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 KRCA-0008 is an effective and specific ALK/Ack1 inhibitor (IC50: 12/4 nM); displays drug-like properties without hERG liability.
靶点活性 Ack1:4 nM, ALK:12 nM
激酶实验 Assay of Abl1 kinase isoforms and determination of inhibitor potency: Activity of u-Abl1native is determined by following the production of ADP from the kinase reaction through coupling with the pyruvate kinase/lactate dehydrogenase system. In this assay, the oxidation of NADH (measured as a decreased A340 nM) is continuously monitored spectrophotometrically. The final reaction mixture (100 μL, in a 384-well Corning plate) is prepared as follows: An Abl1 kinase/coupled assay components mixture is prepared containing u-Abl1 kinase (1 nM), Abltide (EAIYAAPFAKKK, 0.2 mM), MgCl2 (9 mM), pyruvate kinase (~ 4 units), lactate dehydrogenase (~ 0.7 units), phosphoenol pyruvate (1 mM), and NADH (0.28 mM) in 90 mM Tris containing 0.1 % octyl-glucoside and 1 % DMSO, pH 7.5. Separately, an inhibitor mixture is prepared containing DCC-2036 serially diluted 3-fold in DMSO followed by dilution into buffer composed of 180 mM Tris, pH 7.5, containing MgCl2 (18 mM) and 0.2 % octyl-glucoside. Fifty μL of the inhibitor mixture is mixed with 50 μL of the above Abl1 kinase/coupled assay components mixture, which is then incubated at 30 °C for 2 hours before 2 μL of 25 mM ATP (500 μM, final) is added to start the reaction. The reaction is recorded every 2 minutes for 2.5 hours at 30 °C on a Polarstar Optima or Synergy2 plate reader. Reaction rate (slope) is calculated using the 1 to 2 hour time frame with reader's software. Percent inhibition is obtained by comparison of reaction rate with that of a DMSO control. IC50 values are calculated from a series of percent inhibition values determined at a range of inhibitor concentrations using GraphPad Prism. The kinase assay for Abl1T315I, p-Abl1native or Abl1H396P is assayed the same as above except that 2.2 nM Abl1T315I, 1 nM p-Abl1 native or 1.3 nM Abl1H396P is used. The above assay format is also used for kinases other than Abl1 with the exception of TIE2, for which a fluorescence polarization/Transcreener format is used.The assay conditions are the same as described above except that PolyE4Y (final 1 mg/mL) is used as the substrate and one hour preincubation is used.
别名 KRCA 0008, KRCA0008
分子量 609.12
分子式 C30H37ClN8O4
CAS No. 1472795-20-2

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 12 mg/mL (19.7 mM)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO 1 mM 1.6417 mL 8.2086 mL 16.4171 mL 41.0428 mL
5 mM 0.3283 mL 1.6417 mL 3.2834 mL 8.2086 mL
10 mM 0.1642 mL 0.8209 mL 1.6417 mL 4.1043 mL

计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

参考文献

1. Park CH, et al. Bioorg Med Chem Lett. 2013 Nov 15;23(22):6192-6.
AIM-100 Vemurafenib GNF-7 AZ7550

相关化合物库

该产品包含在如下化合物库中:
酪氨酸激酶分子库 血管生成库 NO PAINS 化合物库 抗肺癌化合物库 表型筛选靶点鉴定库 经典已知活性库 激酶抑制剂库 抑制剂库 抗癌化合物库 已知活性化合物库

剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

KRCA-0008 1472795-20-2 Angiogenesis Tyrosine Kinase/Adaptors ACK ALK selective crizotinib Ack1 inhibit diaminopyrimidine analogue TNK2 ALCL N-Acetylpiperidine KRCA 0008 Anaplastic lymphoma kinase (ALK) KRCA0008 cell cycle arrest Anaplastic lymphoma kinase apoptosis Inhibitor ALK tyrosine kinase receptor CD246 Activated Cdc42 kinase 1 Cluster of differentiation 246 inhibitor

 

陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼